Collectively, these results suggest that CaMKK2 promotes a DAM-like phenotype associated with ICB resistance in TAMs and other MNPs, which are the most abundant immune cells in the GBM TME (Fig. 2d and Supplementary Fig. 2b). This evidence concerns the gene CAMKK2 and glioblastoma.